A Short Note on Lacosamide and its Main Metabolite Combined Pharmacokinetic Model

Carina Smith

doi:10.4172/jpet.1000158

Journal of Pharmacokinetics & Experimental Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication
J Pharmacokinet Exp Ther 2022, Vol 6(6): 158
DOI: 10.4172/jpet.1000158

A Short Note on Lacosamide and its Main Metabolite Combined Pharmacokinetic Model

Carina Smith^*: University of Dusseldorf, Institute Clinical Pharmacy and Pharmacotherapy, Dusseldorf, Germany

^*Corresponding Author : Carina Smith, University of Dusseldorf, Institute Clinical Pharmacy and Pharmacotherapy, Dusseldorf, Germany, Email: carina@ucb.com

Received Date: Nov 22, 2022 / Accepted Date: Dec 19, 2022 / Published Date: Dec 20, 2022

View PDF Download PDF

Citation: Smith C (2022) A Short Note on Lacosamide and its Main MetaboliteCombined Pharmacokinetic Model. J Pharmacokinet Exp Ther 6: 158. Doi: 10.4172/jpet.1000158

Copyright: © 2022 Smith C. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.